5DN-15867-75245
3 vaccinations
2 coded responses
30 check-ins
2 free-text entries
1 call case
- Sex
- —
- Age at first dose
- 36-40
- ZIP prefix
- 981 / WA
- Registered
- 2021-01-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-18
Registered in v-safe
-
2021-01-18
Dose 1 — Pfizer-BioNTech
- 2021-01-18
-
2021-01-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness, Swelling · Headache · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-01-20
- 2021-01-21
- 2021-01-22
- 2021-01-23
-
2021-01-24
Survey response — days 1–6 daily, dose 1MedDRA: Migraine — Feeling: Good · HeadacheFree text: Chronic migraines.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-25
- 2021-02-01
-
2021-02-06
Dose 2 — Pfizer-BioNTech
- 2021-02-08
- 2021-02-09
- 2021-02-11
- 2021-02-12
- 2021-02-15
- 2021-02-20
- 2021-02-27
- 2021-03-20
- 2021-05-08
- 2021-08-09
-
2021-09-24
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-09-28
- 2021-09-29
- 2021-10-01
- 2021-10-08
- 2021-10-15
- 2021-10-22
- 2021-10-29
- 2021-11-05
- 2021-12-26
-
2022-03-25
Survey response — 6 months, dose 3MedDRA: Migraine, Oropharyngeal pain, Pre-existing disease, Serum ferritin decreased — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Low ferritin, increased migraine frequency, persistent sore throatMedDRA releases: 2024-11 · check-in free text available
-
2022-03-25
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-28
- 2022-09-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-18 | Pfizer-BioNTech | |
| 2 | 2021-02-06 | Pfizer-BioNTech | |
| 3 | 2021-09-24 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-25 | Unsuccessful |
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Chronic migraines.
Release 11 — 6 months, dose 3
Symptoms: Low ferritin, increased migraine frequency, persistent sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Migraine | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Serum ferritin decreased | · | · | ✓ |
| SRO | Migraine | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release